Left ventricular assist devices: Current controversies and future directions

European Heart Journal

Volumn 37, Issue 46, 2016, Pages 3434-3439b

  Schumer, Erin M ^a   Black, Matthew C ^a   Monreal, Gretel ^a   Slaughter, Mark S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Review; Ventricular assist device

Indexed keywords

HEART FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSATILITY INDEX; QUALITY OF LIFE; REVIEW; HEART ASSIST DEVICE;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; QUALITY OF LIFE;

EID: 85015810705     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv590     Document Type: Review

References (88)

1. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-185; passim.
2. Lim MW. The history of extracorporeal oxygenators. Anaesthesia 2006;61: 984-995.
3. Stewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation 2012;125:1304-1315.
4. Morris PJ. Cyclosporin A. Transplantation 1981;32:349-354.
5. Colombo D, Ammirati E. Cyclosporine in transplantation-A history of converging timelines. J Biol Regul Homeost Agents 2011;25:493-504.
6. Hunt SA, Haddad F. The changing face of heart transplantation. J Am Coll Cardiol 2008;52:587-598.
7. Portner PM, Oyer PE, Pennington DG, Baumgartner WA, Griffith BP, Frist WR, Magilligan DJ Jr, Noon GP, Ramasamy N, Miller PJ et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg 1989;47:142-150.
8. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345: 1435-1443.
9. Capdeville M, Smedira NG. Advances and future directions for mechanical circulatory support. Anesthesiol Clin 2013;31:321-353.
10. Lietz K, Miller LW. Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009;24:246-251.
11. Giridharan GA, Lee TJ, Ising M, Sobieski MA, Koenig SC, Gray LA, Slaughter MS. Miniaturization of mechanical circulatory support systems. Artif Organs 2012;36: 731-739.
12. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH, HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
13. Loyaga-Rendon RY, Plaisance EP, Arena R, Shah K. Exercise physiology, testing, and training in patients supported by a left ventricular assist device. J Heart Lung Transplant 2014;34:1005-1016.
14. Abshire M, Dennison Himmelfarb CR, Russell SD. Functional status in left ventricular assist device-supported patients: A literature review. J Cardiac Fail 2014;20: 973-983.
15. Maciver J, Rao V, Ross HJ. Quality of life for patients supported on a left ventricular assist device. Expert Rev Med Dev 2011;8:325-337.
16. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Miller MA, Timothy Baldwin J, Young JB. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014;33:555-564.
17. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation 2013;127:452-462.
18. Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS. Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Ann Thorac Surg 2011;91:1330-1333; discussion 1333-1334.
19. Ammirati E, Oliva FG, Colombo T, Russo CF, Cipriani MG, Garascia A, Guida V, Colombo G, Verde A, Perna E, Cannata A, Paino R, Martinelli L, Frigerio M. Midterm survival after continuous-flow left ventricular assist device versus heart transplantation. Heart Vessels 2015;1-12.
20. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Timothy Baldwin J, Pinney S, Eduardo Rame J, Miller MA. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 2014;33:12-22.
21. Rame JE, Atluri P, Acker MA. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370:1466-1467.
22. Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370:33-40.
23. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: A systematic review. Circ Heart Fail 2014;7:1003-1013.
24. Miller LW, Guglin M. Patient selection for ventricular assist devices: A moving target. J Am Coll Cardiol 2013;61:1209-1221.
25. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
26. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
27. Soucy KG, Koenig SC, Giridharan GA, Sobieski MA, Slaughter MS. Rotary pumps and diminished pulsatility: do we need a pulse? ASAIO J 2013;59:355-366.
28. Frazier OH. Unforeseen consequences of therapy with continuous-flow pumps. Circ Heart Fail 2010;3:647-649.
29. Cowger J, Rao V, Massey T, Sun B, May-Newman K, Jorde U, Estep JD. Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patients with a continuous-flow left ventricular assist device. J Heart Lung Transplant 2015;34:149-157.
30. Imamura T, Kinugawa K, Nitta D, Hatano M, Kinoshita O, Nawata K, Ono M. Advantage of pulsatility in left ventricular reverse remodeling and aortic insufficiency prevention during left ventricular assist device treatment. Circulation 2015; 79:1994-1999.
31. Hiraoka A, Cohen JE, Shudo Y, MacArthur JWJr, Howard JL, Fairman AS, Atluri P, Kirkpatrick JN, Woo YJ. Evaluation of late aortic insufficiency with continuous flow left ventricular assist devicedagger. Eur J Cardio Thorac Surg 2015;48: 400-406.
32. Soucy KG, Giridharan GA, Choi Y, Sobieski MA, Monreal G, Cheng A, Schumer E, Slaughter MS, Koenig SC. Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure. J Heart Lung Transplant 2015;34:122-131.
33. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316-1324.
34. Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Yuzefpolskaya M, Mancini DM, Naka Y. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. J Heart Lung Transplant 2015;34:89-99.
35. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006;25:1-6.
36. Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, Russell SD, Conte JV. Right heart dysfunction after left ventricular assist device implantation: A comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008;86:832-840; discussion 832-840.
37. John R, Lee S, Eckman P, Liao K. Right ventricular failure-A continuing problem in patients with left ventricular assist device support. J Cardiovasc Transl Res 2010;3: 604-611.
38. Drews T, Jurmann M, Michael D, Miralem P,Weng Y, Hetzer R. Differences in pulsatile and non-pulsatile mechanical circulatory support in long-term use. J Heart Lung Transplant 2008;27:1096-1101.
39. Giridharan GA, Koenig SC, Soucy KG, Choi Y, Pirbodaghi T, Bartoli CR, Monreal G, Sobieski MA, Schumer E, Cheng A, Slaughter MS. Left ventricular volume unloading with axial and centrifugal rotary blood pumps. ASAIO J 2015;61:292-300.
40. Harvey L, Holley CT, John R. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg 2014;3:475-479.
41. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011;30:849-853.
42. Dassanayaka S, Slaughter MS, Bartoli CR. Mechanistic pathway(s) of acquired von Willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings. ASAIO J 2013;59:123-129.
43. Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail 2011;4:779-784.
44. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208-215.
45. Moazami N, Fukamachi K, Kobayashi M, Smedira NG, Hoercher KJ, Massiello A, Lee S, Horvath DJ, Starling RC. Axial and centrifugal continuous-flow rotary pumps: A translation from pump mechanics to clinical practice. J Heart Lung Transplant 2013;32:1-11.
46. Saito S, Yamazaki K, Nishinaka T, Ichihara Y, Ono M, Kyo S, Nishimura T, Nakatani T, Toda K, Sawa Y, Tominaga R, Tanoue T, Saiki Y, Matsui Y, Takemura T, Niinami H, Matsumiya G; J-MACS Research Group. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS. J Heart Lung Transplant 2014;33:599-608.
47. Kashiyama N, Toda K, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Yoshioka D, Saito T, Sawa Y. Initial experience of EVAHEART explantation after continuousflow LVAD off test with percutaneous occlusion balloon. J Artif Organs 2014;17: 366-369.
48. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: The current picture. J Heart Lung Transplant 2009;28:535-541.
49. Uriel N, Jorde UP,Woo Pak S, Jiang J, Clerkin K, Takayama H, Naka Y, Schulze PC, Mancini DM. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. J Heart Lung Transplant 2013;32:188-195.
50. Stehlik J, Stevenson LW, Edwards LB, Crespo-Leiro MG, Delgado JF, Dorent R, Frigerio M, Macdonald P, MacGowan GA, Nanni Costa A, Rogers JG, Shah AS, Taylor R, Venkateswaran RV, Mehra MR. Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. J Heart Lung Transplant 2014;33:975-984.
51. Trivedi JR, Cheng A, Singh R, Williams ML, Slaughter MS. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. Ann Thorac Surg 2014;98:830-834.
52. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015;131:e29-322.
53. Wittwer T,Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transplant Int 2008;21:113-125.
54. Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, Zuckermann A. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant 2012;31:387-397.
55. Trivedi JR, Ising M, Cheng A, Lenneman A, Birks E, Slaughter MS. Heart Transplant Survival Based on Recipient and Donor Risk Scoring: A UNOS Database Analysis. J Heart Lung Transplant 2015;34:S32-S33.
56. Schumer EM, Ising MS, Trivedi JR, Slaughter MS, Cheng A. Early outcomes with marginal donor hearts compared with left ventricular assist device support in patients with advanced heart failure. Ann Thorac Surg 2015;100:522-527.
57. Daneshmand MA, Krishnamoorthy A, Samsky MD, Felker GM, Pura JA, Lokhnygina Y, Hernandez AF, Rosenberg PB, Blue LJ, Schroder JN, Rogers JG, Milano CA, Patel CB. Comparison of 2-year outcomes of extended criteria cardiac transplantation versus destination left ventricular assist device therapy using continuous flow. Am J Cardiol 2015;116:573-579.
58. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010;122:173-183.
59. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: The REVIVE-IT pilot trial. J Card Fail 2010;16:855-858.
60. Rosenbaum AN, John R, Liao KK, Adatya S, Colvin-Adams MM, Pritzker M, Eckman PM. Survival in elderly patients supported with continuous flow left ventricular assist device as bridge to transplantation or destination therapy. J Card Fail 2014;20:161-167.
61. Modica M, Ferratini M, Torri A, Oliva F, Martinelli L, De Maria R, Frigerio M. Quality of life and emotional distress early after left ventricular assist device implant: A mixed-method study. Artif Organs 2015;39:220-227.
62. Grady KL, Magasi S, Hahn EA, Buono S, McGee EC Jr, Yancy C. Health-related quality of life in mechanical circulatory support: development of a new conceptual model and items for self-administration. J Heart Lung Transplant 2015;34:1292-1304.
63. Grady KL, Naftel DC, Myers S, Dew MA,Weidner G, Spertus JA, Idrissi K, Lee HB, McGee EC, Kirklin JK. Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: analyses from INTERMACS. J Heart Lung Transplant 2015;34:213-221.
64. Smedira NG, Hoercher KJ, Lima B, Mountis MM, Starling RC, Thuita L, Schmuhl DM, Blackstone EH. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 2013;1:31-39.
65. Sharma V, Deo SV, Stulak JM, Durham LA 3rd, Daly RC, Park SJ, Baddour LM, Mehra K, Joyce LD. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 2012;94:1381-1386.
66. Tsiouris A, Paone G, NemehHW, Brewer RJ, Morgan JA. Factors determining postoperative readmissions after left ventricular assist device implantation. J Heart Lung Transplant 2014;33:1041-1047.
67. Forest SJ, Bello R, Friedmann P, Casazza D, Nucci C, Shin JJ, D'Alessandro D, Stevens G, Goldstein DJ. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 2013;95:1276-1281.
68. Slaughter MS, Myers TJ. Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects. J Cardiac Surg 2010;25:484-489.
69. Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, Moore CH, Loisance DY, El-Banayosy A, Frazier H. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002; 21:516-521.
70. Birks EJ, George RS, Hedger M, Bahrami T, Wilton P, Bowles CT, Webb C, Bougard R, Amrani M, Yacoub MH, Dreyfus G, Khaghani A. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: A prospective study. Circulation 2011;123:381-390.
71. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-1884.
72. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008;118(14 Suppl.):S94-105.
73. Dandel M, Weng Y, Siniawski H, Stepanenko A, Krabatsch T, Potapov E, Lehmkuhl HB, Knosalla C, Hetzer R. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J 2011;32:1148-1160.
74. Dandel M, Weng Y, Siniawski H, Potapov E, Krabatsch T, Lehmkuhl HB, Drews T, Knosalla C, Hetzer R. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation 2012;126(11 Suppl. 1):S9-19.
75. Dandel M, Knosalla C, Hetzer R. Contribution of ventricular assist devices to the recovery of failing hearts: A review and the Berlin Heart Center Experience. Eur J Heart Fail 2014;16:248-263.
76. Mano A, Nakatani T, Oda N, Kato T, Niwaya K, Tagusari O, Nakajima H, Funatsu T, Hashimoto S, Komamura K, Hanatani A, Ueda IH, Kitakaze M, Kobayashi J, Yagihara T, Kitamura S. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system? J Heart Lung Transplant 2008; 27:869-874.
77. Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ. Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery. Eur J Cardio Thorac Surg 2013;43:379-382.
78. Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, Winowich S, McNamara DM. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005;112(9 Suppl.):I32-I36.
79. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 2004;109: 2263-2265.
80. Wohlschlaeger J, Schmitz KJ, Schmid C, Schmid KW, Keul P, Takeda A, Weis S, Levkau B, Baba HA. Reverse remodeling following insertion of left ventricular assist devices (LVAD): A review of the morphological and molecular changes. Cardiovasc Res 2005;68:376-386.
81. Birks EJ, Hall JL, Barton PJ, Grindle S, Latif N, Hardy JP, Rider JE, Banner NR, Khaghani A, Miller LW, Yacoub MH. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation. 2005; 112(9 Suppl.):I57-I64.
82. Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol 2012;60:2465-2472.
83. Soucy KG, Smith EF, Monreal G, Rokosh G, Keller BB, Yuan F, Matheny RG, Fallon AM, Lewis BC, Sherwood LC, Sobieski MA, Giridharan GA, Koenig SC, Slaughter MS. Feasibility study of particulate extracellular matrix (P-ECM) and left ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine model. ASAIO J 2015;61:161-169.
84. Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 2011; 50:258-265.
85. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: A systematic review and meta-analysis. Circulation 2012;126: 551-568.
86. Tongers J, LosordoDW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011;32: 1197-1206.
87. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-321.
88. Slaughter MS, Pagani FD, McGee EC, Birks EJ, Cotts WG, Gregoric I, Howard Frazier O, Icenogle T, Najjar SS, Boyce SW, Acker MA, John R, Hathaway DR, Najarian KB, Aaronson KD; HeartWare Bridge to Transplant ADVANCE Trial Investigators. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2013;32:675-683.